Meeder Asset Management Inc. bought a new position in shares of Maximus, Inc. (NYSE:MMS - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 18,849 shares of the health services provider's stock, valued at approximately $1,407,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in MMS. Nordea Investment Management AB purchased a new position in Maximus during the fourth quarter worth about $4,618,000. Fort Washington Investment Advisors Inc. OH increased its position in Maximus by 39.1% during the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider's stock worth $22,132,000 after purchasing an additional 83,390 shares during the last quarter. IFP Advisors Inc boosted its holdings in Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after acquiring an additional 302 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new stake in Maximus in the 4th quarter valued at $1,113,000. Finally, Legato Capital Management LLC grew its position in Maximus by 33.9% in the fourth quarter. Legato Capital Management LLC now owns 32,134 shares of the health services provider's stock valued at $2,399,000 after acquiring an additional 8,138 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.
Wall Street Analysts Forecast Growth
Several analysts have issued reports on the company. StockNews.com cut Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th. Raymond James upgraded shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective on the stock in a research report on Thursday, January 2nd.
Check Out Our Latest Research Report on Maximus
Insider Activity
In other Maximus news, Director Jan Madsen sold 2,439 shares of the firm's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now directly owns 18,097 shares in the company, valued at approximately $1,225,347.87. This trade represents a 11.88 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the transaction, the insider now owns 2,512 shares of the company's stock, valued at approximately $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.
Maximus Stock Performance
MMS stock traded down $0.60 during midday trading on Thursday, hitting $70.43. 303,801 shares of the company traded hands, compared to its average volume of 536,482. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97. The business has a 50 day simple moving average of $69.44 and a 200-day simple moving average of $77.46. The stock has a market capitalization of $3.99 billion, a price-to-earnings ratio of 15.13 and a beta of 0.71.
Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating analysts' consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. As a group, equities research analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current year.
Maximus Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.70%. Maximus's payout ratio is presently 25.81%.
Maximus Company Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Articles

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.